All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Dopamine Agonist | NCIT_C66884 | [Any agent that binds to and activates dopamine receptors.] |
| Butantrone | NCIT_C74164 | [The 10-butyryl derivative of dithranol with antipsoriatic activity.] |
| Anti-psoriatic Agent | NCIT_C29708 | [Used topically or systemically, natural or synthetic Anti-psoriatic agents relieve symptoms of psoriasis by controlling rapid growth of skin cells, reducing DNA synthesis and mitotic activity in hyperplastic epidermis, and restoring normal epidermal cell proliferation and keratinization. (NCI04)] |
| Pentabamate | NCIT_C74165 | |
| Tibenzate | NCIT_C74160 | |
| Antiparasitic Agent | NCIT_C276 | [Any agent that is effective against infections caused by parasitic organisms and is able to inhibit their growth or kill them. This class consists of anthelmintics and antiprotozoals.] |
| Bromociclen | NCIT_C74161 | |
| Phenyliodoundecynoate | NCIT_C74159 | |
| Ritiometan | NCIT_C74155 | [An antibacterial agent used in an aerosol preparation for the treatment of infections of the nose and throat.] |
| Antibacterial Agent | NCIT_C52588 | [A family of substances capable of destroying or inhibiting the growth of bacteria.] |
| Bibrocathol | NCIT_C74156 | [A bismuth derivative of tetrabromopyrocatechol used as a topical ointment for the treatment of blepharitis.] |
| Topical Anti-Infective Agent | NCIT_C28394 | [A natural or synthetic agent used for local application on skin, mucosa, or cavities, a Topical Anti-Infective Agent, formulated as a sterile solution or cream, commonly displays therapeutic or prophylactic antibiotic properties against infectious viral, bacterial, or protozoal agents by inhibiting growth and survival. (NCI04)] |
| Oxitropium Bromide | NCIT_C74157 | |
| Idebenone | NCIT_C74158 | |
| Carcinoma of the Lacrimal Gland pT2 TNM Finding v7 | NCIT_C88792 | [Carcinoma of the lacrimal gland with tumor measuring more than 2 cm but not more than 4 cm in greatest dimension. Note: As the maximum size of the lacrimal gland is 2 cm, T2 and greater tumors will usually extend into the orbital soft tissue. (from AJCC 7th Ed.)] |
| Carcinoma of the Lacrimal Gland pT3 TNM Finding v7 | NCIT_C88793 | [Carcinoma of the lacrimal gland with tumor measuring more than 4 cm in greatest dimension. Note: As the maximum size of the lacrimal gland is 2 cm, T2 and greater tumors will usually extend into the orbital soft tissue. (from AJCC 7th Ed.)] |
| Carcinoma of the Lacrimal Gland pT4a TNM Finding v7 | NCIT_C88795 | [Carcinoma of the lacrimal gland with tumor invading periosteum. (from AJCC 7th Ed.)] |
| Carcinoma of the Lacrimal Gland pT1 TNM Finding v7 | NCIT_C88790 | [Carcinoma of the lacrimal gland with tumor measuring 2 cm or less in greatest dimension with or without extraglandular extension into the orbital soft tissue. (from AJCC 7th Ed.)] |
| Sifaprazine | NCIT_C74190 | |
| Broxaterol | NCIT_C74195 |